Ozempic

In a significant shift in strategy, Australia’s leading weight loss drug-selling start-up, Eucalyptus, has started offering Ozempic, a medication traditionally used for Type 2 diabetes treatment in the country, reports the Australian Financial Review. This comes after the company’s...

Novo Nordisk A/S (OTC:NONOF) manufactured diabetes and weight loss drug Ozempic, known scientifically as semaglutide, may have the potential to help break addictions, The Guardian reports. Unexpected Changes Users of the drug have reported a decrease in addictive behaviors, such as smoking and...

Pharmaceutical company Novo Nordisk is set to introduce a pill version of its popular weight-loss drug, Ozempic. However, the convenience of a pill may be overshadowed by the requirement of daily fasting and potential for misuse. What Happened: The pill version of Ozempic, known as semaglutide, has...

Doctors are advising patients on weight loss drugs like Novo Nordisk’s Ozempic and Wegovy to stop taking them before elective surgery to reduce the risk of serious health complications. What Happened: The American Society of Anesthesiologists (ASA) released interim guidance suggesting that...

While the diabetes medications Ozempic and Wegovy can aid in weight loss, they alone do not guarantee good health, The Wall Street Journal reports. Exercise and Nutrition Still Matter According to the Wall Street Journal, exercise remains crucial for heart health and muscle strength, even for those...

Groundbreaking data from Eli Lilly & Co. (NYSE:LLY) has sparked a new conversation about obesity treatments, with their experimental drug, retatrutide, showing astonishing weight loss results, Bloomberg reports. Unprecedented Weight Loss Retatrutide has demonstrated remarkable efficacy in a mid...

Startups may be entering the “age of Ozempic,” according to Aileen Lee, partner at Cowboy Ventures. Lee made the comment at a Bloomberg Technology conference held Thursday, likening the current fiscal tightening in Silicon Valley to the effects of the popular weight loss drug Ozempic....

The race to develop weight-loss drugs more potent than the popular Ozempic is heating up, with several promising contenders on the horizon, The Wall Street Journal reports. Novo Nordisk’s (NYSE:NVO) Ozempic and Eli Lilly’s (NYSE:LLY) Mounjaro have seen a surge in demand due to their...

Insulin-resistance drugs, such as those containing the compound semaglutide, could potentially aid in treating neurodegenerative disorders like Parkinson's disease, PsyPost reports. Insulin Resistance Drugs and Parkinson’s Research indicates that semaglutide, found in medications like Ozempic...

The potential for weight loss drugs has caught the attention of Wall Street, with the prospect of a pill for obesity promising to revolutionize the market, The Wall Street Journal reports. Ozempic and Wegovy, produced by Novo Nordisk (NYSE:NVO), and Mounjaro, by Eli Lilly Inc. (NYSE:LLY), are...

Jackie Goldschneider, star of “Real Housewives of New Jersey,” said she will not be joining her fellow housewives in using the diabetes-turned-weight-loss drug Ozempic. What Happened: Goldschneider made her stance clear on Saturday, commenting on a Page Six Instagram post about Emily...

Pharmaceutical company Novo Nordisk (NYSE:NVO) announced on Sunday that a late-stage trial of its high-dose oral drug semaglutide led to a 15% body weight loss in overweight or obese adults. What Happened: The Danish company plans to seek U.S. and European regulatory approval of the high-dose pill...

Pharmaceutical giants are developing pill versions of popular injectable weight-loss drugs like Ozempic, aiming to appeal to needle-averse patients and potentially cost less, The Wall Street Journal reports. Why Pills? While injectable drugs such as Ozempic have gained popularity for their weight...

The diabetes drug Ozempic, manufactured by Novo Nordisk, is gaining attention not only for its primary use but also for its off-label application in weight loss and an expert is warning against the trend, CBC News reports. What is Ozempic? Approved by Health Canada in 2018 for treating adults with...

A new clinical trial has shown that Mounjaro, a diabetes drug similar to Ozempic and Wegovy, could be a game-changer in the field of weight loss, Insider reports. Mounjaro, developed by Eli Lilly and Co. (NYSE:LLY), was approved for treating type 2 diabetes in May 2022. The latest data suggests...